A003090 Stock Overview
Engages in the manufacture and sale of pharmaceuticals in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Daewoong Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩25,650.00 |
| 52 Week High | ₩27,100.00 |
| 52 Week Low | ₩13,100.00 |
| Beta | 1.22 |
| 11 Month Change | 26.35% |
| 3 Month Change | 57.07% |
| 1 Year Change | 81.53% |
| 33 Year Change | -29.63% |
| 5 Year Change | 48.70% |
| Change since IPO | 1,080.15% |
Recent News & Updates
Daewoong Co., Ltd. (KRX:003090) Held Back By Insufficient Growth Even After Shares Climb 26%
Sep 01
Daewoong Co., Ltd.'s (KRX:003090) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jul 14Is Daewoong (KRX:003090) Using Too Much Debt?
Jul 04Does Daewoong (KRX:003090) Have A Healthy Balance Sheet?
Apr 02Recent updates
Daewoong Co., Ltd. (KRX:003090) Held Back By Insufficient Growth Even After Shares Climb 26%
Sep 01Daewoong Co., Ltd.'s (KRX:003090) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jul 14Is Daewoong (KRX:003090) Using Too Much Debt?
Jul 04Does Daewoong (KRX:003090) Have A Healthy Balance Sheet?
Apr 02With EPS Growth And More, Daewoong (KRX:003090) Is Interesting
Apr 13A Look At The Intrinsic Value Of Daewoong Co., Ltd. (KRX:003090)
Mar 29Daewoong Co., Ltd. (KRX:003090) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Mar 14Daewoong (KRX:003090) Seems To Use Debt Quite Sensibly
Feb 21The Daewoong (KRX:003090) Share Price Has Soared 308%, Delighting Many Shareholders
Jan 31
Do Its Financials Have Any Role To Play In Driving Daewoong Co., Ltd.'s (KRX:003090) Stock Up Recently?
Dec 04Shareholder Returns
| A003090 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 5.8% | 6.8% | -1.0% |
| 1Y | 81.5% | 23.1% | 1.0% |
Return vs Industry: A003090 exceeded the KR Pharmaceuticals industry which returned 23.1% over the past year.
Return vs Market: A003090 exceeded the KR Market which returned 1% over the past year.
Price Volatility
| A003090 volatility | |
|---|---|
| A003090 Average Weekly Movement | 10.7% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.1% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A003090's share price has been volatile over the past 3 months.
Volatility Over Time: A003090's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 353 | Yeong-Hwan Yoon | www.daewoongholdings.com |
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd.
Daewoong Co., Ltd. Fundamentals Summary
| A003090 fundamental statistics | |
|---|---|
| Market cap | ₩1.05t |
| Earnings (TTM) | ₩118.20b |
| Revenue (TTM) | ₩1.83t |
8.9x
P/E Ratio0.6x
P/S RatioIs A003090 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A003090 income statement (TTM) | |
|---|---|
| Revenue | ₩1.83t |
| Cost of Revenue | ₩884.36b |
| Gross Profit | ₩941.36b |
| Other Expenses | ₩823.16b |
| Earnings | ₩118.20b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.89k |
| Gross Margin | 51.56% |
| Net Profit Margin | 6.47% |
| Debt/Equity Ratio | 39.4% |
How did A003090 perform over the long term?
See historical performance and comparison